SITraN, Verge Partner to Develop, Advance to Trial New Therapeutic Targets

SITraN, Verge Partner to Develop, Advance to Trial New Therapeutic Targets

286884

SITraN, Verge Partner to Develop, Advance to Trial New Therapeutic Targets

The Sheffield Institute for Translational Neuroscience, known as SITraN, has joined with Verge Genomics to develop new therapeutic targets and screen the latest compounds for the treatment of neurodegenerative disorders such as Parkinson’s disease. The aim of this partnership is to accelerate the validation of new therapeutic candidates for Parkinson’s and other diseases and to rapidly advance them into clinical studies. “This collaboration strengthens our mission to find treatments for patients with neurodegenerative diseases,” Jane…

You must be logged in to read/download the full post.